Lyrica

Type: Product

Name: Lyrica

First reported May 24 2013 - Updated May 24 2013 - 1 reports

Divi's Labs: Short term pain, long term positive

The stock of drug firm Divi's Labs has corrected 12% since the company announced its March quarter at the beginning of this week. The company, which is engaged in the contract manufacturing services, has been a favourite among the investors since the ... [Published Economic Times - May 24 2013]

Entities: Divis Laboratories Ltd, Fiscal Year, Irbesartan, Valsartan, Lyrica

First reported May 24 2013 - Updated May 24 2013 - 2 reports

Pfizer Inc

Pfizer Has Potential To Grow Despite Decreasing Sales

Home » Blogs » Pfizer (PFE) is the world's largest research-based pharmaceutical company. It discovers, manufactures and leads the global market in prescription drugs and healthcare products. The company is struggling with deteriorating sales due to the ... [Published BioPortfolio - May 24 2013]

Entities: Pfizer Inc, Patent, Health Care, Biotechnology, Emerging Markets

First reported May 22 2013 - Updated May 22 2013 - 1 reports

Lyrica

Lyrica Discount Cards Now Available From MedicationDiscountCard.com

The health care crisis in the United States is far from solved. In some states, up to twenty-seven percent of all adults are without health insurance. Further, roughly half of all bankruptcies of private citizens in the U.S. are related to medical bills. ... [Published Zecco - May 22 2013]

Entities: Lyrica, Discount, Drugs

First reported May 21 2013 - Updated May 21 2013 - 1 reports

Catalyst Pharmaceutical's CPP-115 May Be Big Pipeline In Just One Little Pill

Be Big Pipeline In Just One Little PillI've been searching and researching for new drugs that have a high potential to become blockbusters and big stock winners and I came across one that looks particularly interesting. CPP-115 is an exciting new drug ... [Published BioPortfolio - May 21 2013]

Entities: Pipeline, Catalyst, Lyrica, Drugs, Neurontin

First reported May 10 2013 - Updated May 10 2013 - 1 reports

Plans to grow Choral Festival for 2014

Scoil Mhuire Kanturk perform as part of the Composers In the Classroom programme as part of the Cork International Choral Festival at the Millenium Hall, Cork City Hall. Picture: Clare KeoghPlans are already in place to grow the Cork International Choral ... [Published TheCorkNews.ie - May 10 2013]

Entities: Sinéad Madden, Lyrica, Ireland, Dublin

First reported May 08 2013 - Updated May 08 2013 - 1 reports

Ars Lyrica Houston announces its 10th anniversary season

2011 Grammy nominee Ars Lyrica Houston announces its 2013/14 season, which celebrates the organization’s 10th anniversary and its mission to revive the musical glories of the Baroque era, the “golden age” of Western art. This season of Discoveries features ... [Published Cleveland Advocate - May 08 2013]

Entities: Lyrica, ARS++, Houston (Texas, United States), Alessandro Scarlatti, Antonio Vivaldi

First reported May 02 2013 - Updated May 02 2013 - 1 reports

Does Using a Step Therapy Program for Pregabalin Reduce Healthcare Costs?

Editor's comment: Step Therapy is a term used to describe a practice used by many insurance companies that requires physicians to begin drug therapy for a medical condition with the most cost-effective and safest drug therapy available, progressing to ... [Published Pro Health Network - May 02 2013]

Entities: Pregabalin, Lyrica, Health Care

First reported Apr 30 2013 - Updated May 01 2013 - 2 reports

Pfizer sales down 9% but pleased with pipeline progress

Pfizer has cut its earnings forecast for 2012 after posting disappointing sales for the first quarter, hit by loss of exclusivity on the cholesterol drug Lipitor and a weak performance from the pneumococcal disease vaccine Prevnar 13.Net income came in ... [Published Pharma Times - May 01 2013]

Entities: Pfizer Inc, Lipitor, Prevnar, Enbrel, Celebrex

First reported Apr 30 2013 - Updated May 01 2013 - 3 reports

Pfizer, Zoetis Earnings A Study In Contrasts

Posted 11:09 AM ETBig pharma Pfizer (PFE) and its animal-health affiliate Zoetis (ZTS) delivered sharply different earnings reports early Tuesday, sending their stocks in different directions.Zoetis brought the good news. Adjusted net income was 36 cents ... [Published Investors Business Daily - Apr 30 2013]

Entities: Zoetis Inc, Pfizer Inc, Mark Schoenebaum, Idexx Laboratories Inc

First reported Apr 30 2013 - Updated Apr 30 2013 - 2 reports

Pfizer 1st-Quarter Profit Up 53% on One-Time ...

By Tess Stynes Pfizer Inc.'s (PFE) first-quarter earnings rose 53% as the world's largest drug maker by sales benefited from gains related to the company's China joint venture, asset sales and other items.Shares were down 3% at $29.49 in premarket trading ... [Published ADVFN UK - Apr 30 2013]

Entities: Pfizer Inc, Lipitor, Drugs, Lyrica, Zoetis Inc

First reported Apr 26 2013 - Updated Apr 26 2013 - 1 reports

LYRICA (Pregabalin) Capsule [Cardinal Health]

Updated Date: Apr 26, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Apr 26 2013]

Entities: Lyrica, Cardinal Health Inc

First reported Apr 26 2013 - Updated Apr 26 2013 - 1 reports

LYRICA (Pregabalin) Capsule [Bryant Ranch Prepack]

Updated Date: Apr 26, 2013 EST ... [Published DailyMed Drug Label Updates for the last seven ... - Apr 26 2013]

Entities: Lyrica

Quotes

Jeremy Duboys, President of MedicationDiscountCard.com, explains his mission, "We are aware that millions of Americans are losing out on healthcare because prescription prices are too high. That's why our card offers you a discount of up to 75% on thousands of prescription drugs." Duboys believes that everyone deserves to be able to refill their prescriptions so they can be taken regularly. MedicationDiscountCard...

Lyrica Discount Cards Now Available From MedicationDiscountCard.com [Published Zecco - May 22 2013]

Original Article: More From BioPortfolio on "Catalyst Pharmaceutical's CPP-115 May Be Big Pipeline In Just One Little Pill"

Catalyst Pharmaceutical's CPP-115 May Be Big Pipeline In Just One Little Pill [Published BioPortfolio - May 21 2013]

Pfizer's Australia managing director, Mr JohnJohn Latham, explained the reason: "In order to develop stronger partnerships with pharmacists and better adapt to the changing environment, we have decided that a dedicated field force with specific pharmacy experience and a direct distribution model for all our prescription medicines sold into community pharmacy are critical." After losing patent protection on Lipitor and some other well-known brands, by re-establishing relationships with pharmacies, Pfizer had a better chance...

Pfizer's Direct-To-Consumer Campaigns: A Model For The Future? [Published Seeking Alpha - May 13 2013]

...Analysts estimate FDA's ruling could delay Tresiba until 2015, with some placing the drug's entry as late as 2016. "The U S represents something like 50% of our growth potential" said Sorensen

Business Briefs Merck, GSK, Novo, Walgreen, Epocrates, Doximity [Published Medical Marketing And Media - May 09 2013]

More Content

sort by: Date \| Relevance
Divi's Labs: Short term pain, long term positive [Published Economic Times - May 24 2013]
Pfizer Has Potential To Grow Despite Decreasing... [Published BioPortfolio - May 24 2013]
Offer Update [Published TrustNet - May 24 2013]
Pfizer Has Potential To Grow Despite Decreasing... [Published Seeking Alpha - May 24 2013]
Lyrica Discount Cards Now Available From Medica... [Published Zecco - May 22 2013]
Bayer, Pfizer Accused of Making False Claims Ab... [Published Mercola - May 22 2013]
Catalyst Pharmaceutical's CPP-115 May Be Big Pi... [Published BioPortfolio - May 21 2013]
Royalty Pharma Increases Offer for Elan to $12.... [Published Scottrade - May 20 2013]
Royalty Pharma Increases Offer for Elan to $12.... [Published FinanzNachrichten.de - May 20 2013]
Catalyst Pharmaceutical's CPP-115 May Be Big Pi... [Published Seeking Alpha - May 20 2013]
Dr Le Fanu's online health clinic, Friday 17 Ma... [Published Telegraph - May 17 2013]
Event takes classic approach [Published Muskogee Phoenix - May 17 2013]
Medical marijuana: no pain, no brain [Published Stowe Reporter - May 17 2013]
Buying Pfizer Stock Brings a Great Dividend [Published Motley Fool Discussion Boards - May 15 2013]
Results of Switching Fibromyalgia Patients from... [Published Pro Health Network - May 15 2013]
Abstract: Results of Switching Fibromyalgia Pat... [Published Pro Health Network - May 15 2013]
Pfizer's Direct-To-Consumer Campaigns: A Model ... [Published Seeking Alpha - May 13 2013]
Buying the Pharma Dips [Published Motley Fool - May 13 2013]
This Is Your Brain On Restless Leg Syndrome [Published Psychology Today - May 13 2013]
St. John's Wort [Published BellaOnline - May 12 2013]
‘Fibro Fighter’ struggles with fatigue, debilit... [Published Cullman Times - May 12 2013]
Plans to grow Choral Festival for 2014 [Published TheCorkNews.ie - May 10 2013]
Business Briefs Merck, GSK, Novo, Walgreen, Epo... [Published Medical Marketing And Media - May 09 2013]
Nektar Therapeutics Reports Financial Results f... [Published Street Insider - May 09 2013]
Nektar Therapeutics Reports Financial Results f... [Published TickerTech.com - May 09 2013]
BioDelivery Sciences Provides Business Review a... [Published TickerTech.com - May 09 2013]
BioDelivery Sciences Provides Business Review a... [Published ABC News 4 Charleston - May 09 2013]
Review Of Depomed First Quarter 2013 Results [Published Seeking Alpha - May 09 2013]
Uncle Bansal’s Gravy Train [Published Tehelka - May 09 2013]
LYRICA (Pregabalin) Capsule [A-S Medication Sol... [Published DailyMed Drug Label Updates for the last seven ... - May 09 2013]

sort by: Date \| Relevance
For Postherpetic Neuralgia, Current and Emergin... [Published PR Newswire: General Business - Apr 09 2013]
Research and Markets: Lyrica (Epilepsy) - Forec... [Published Business Wire Health News - Mar 08 2013]
Top-Line Data Show Lyrica Met Primary Endpoint ... [Published EON Health & Medicine - Feb 21 2013]
Top-Line Data Show Lyrica Met Primary Endpoint ... [Published Business Wire Health News - Feb 21 2013]
Treatment Algorithms: Postherpetic Neuralgia - ... [Published PR Newswire: General Business - Dec 17 2012]